R- ment was repeated for 6 weeks (5-day treatment and 2-day interval weekly). The PD50 was determined 8 weeks after the infection. Plasma levels Groups of 5 female CDI Cobs mice were treated orally or subcutaneously with 50 mg/kg of the compounds prepared as described in (a). After 30, 60, 120, 240, 420 minutes 3 mice/group were sacrificed, the heparinated blood was collected, pooled, and centrifuged. The separated plasma was stored at -20°C before microbiological assay on Sarcina lutea ATCC 93418) .
Tissue levels Groups of 5 male CD rats weighing about 200 g, treated orally with 50 mg/kg of the compounds prepared as described in (a), were sacrificed 4 hours after treatment. Plasma, lung, liver and spleen were removed, homogenized in pH 7 phosphate buffer and used for microbiological assay on Sarcina lutea ATCC 93418).
Results Table I reports the chemical structure and the Rf values on thin-layer chromatography of the new derivatives. Rf values increase with increasing the number of carbon atoms of the radical (R) but do not appear to be substantially affected by branching.
The MICs of the compounds on five representative strains of Schizomycetes are reported in Table 2 . The parent compound (1) displays a broad-spectrum antibacterial activity which is slightly modified in the series of homologous compounds bearing linear alkyl chains from I to 7 carbons. With respect to the compound 1 there is a tendency towards an increased potency on S. aureus and even more on M.
tuberculosis, whereas there is a lowered efficacy against strains of E. coli, both rifampicin-sensitive (E.
coli B, E. coli ginetta strain) and rifampicin-resistant (E. coli C1). It is to be noted that this latter strain maintains a good degree of sensitivity to the lower homologues of the series of spiro-piperidyl-rifamycins in spite of being rifampicin resistant.
The pattern observed is in accordance with the increasing lipophilic nature of the compounds within the series, as expressed by the Rf values reported in Table 1 .
When the isomers with 3, 4 and 5 carbons in the side chain are considered, the only relevant observations are the high activity of compound 9 against S. aureus and the increased activity of compounds 13 and 14 over that of the unbranched isomers.
The plasma levels in mice within 7 hours and the therapeutic efficacy are summarized in Tables 3 and 4.
In Table 3 the areas under the plasma curves (AUC), the time of appearance (t max) and the values of the peaks (C max) in the plasma are reported after oral and subcutaneous administration.
The AUC after oral administration is negligible for the parent compound (1), whereas the homologous derivatives with longer linear aliphatic chains show increased AUCs up to the compound 7, after which the AUC considerably decreases again (compound 8). This break point is confirmed by s.c.
administration.
The ratio AUC p.o./AUC s.c. increases gradually along the series of the homologous compounds suggesting the importance of lipid solubility for gastrointestinal absorption. The t maxs are delayed along the series of unbranched derivatives, both after oral and subcutaneous administration, whereas the C maxs are rather homogeneous, with the exception of compounds 1 and 8.
Within the isomers, the branched compounds frequently show better bioavailability, delayed t maxs and/or longer persistance of the C max compared with the linear analogues (compounds 10, 11, 12, 13).
The median protective doses (PD50) in mice either against S. aureus or S. abortivoequina infections (Table 4 ) are in a good agreement with the potency and plasma level characteristics of the substances for the extreme members of the series only (compounds 1 and 8), although some correlation may be seen also within the whole class. For the M. tuberculosis infection, it is difficult, and probably faulty, to seek an analogous correlation because of the characteristics of the disease and of the extended treatment regimen. Nevertheless, the very good therapeutic effectiveness on M. (Table  5) .
Discussion
The spiro-piperidyl-rifamycins, a new class 
